Lectins and applications for the detection of pathological state markers

US10247734B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10247734-B2
Application numberUS-201515123138-A
CountryUS
Kind codeB2
Filing dateFeb 26, 2015
Priority dateMar 4, 2014
Publication dateApr 2, 2019
Grant dateApr 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Multimenic lectins having a β-propeller architecture, formed from monomer modules of approximately 30 to 60 amino acids, in which the binding sites to the glycans are situated on a given side of the proteins and the O-terminus and N-terminus ends of the peptide chains on the other side of the proteins, characterized in that they are formed from 4 to 7 monomer modules, a single, or a plurality of, or all of the adjacent modules being linked to one another by the linkers linking the N-terminus end of one module to the C-terminus end of the adjacent module.

First claim

Opening claim text (preview).

The invention claimed is: 1. A monomeric, single polypeptide chain lectin having a β-propeller architecture, said lectin comprising 4 to 7 peptide modules, wherein each module comprises about 30 to 60 amino acids; wherein each module comprises a glycan binding site; wherein at least one glycan binding site comprises at least one mutation, said mutation altering glycan binding; wherein each module is linked to another module with a peptide linker; and wherein at least one peptide linker is an exogenous peptide linker. 2. The lectin of claim 1 , wherein the peptide linkers are the same or different, wherein the peptide linkers comprises 2 to 10 amino acids. 3. The lectin of claim 1 , wherein the lectin is multivalent and capable of binding more than one glycan or the lectin is monovalent and binds a single glycan. 4. The lectin of claim 1 , wherein the lectins comprises one or more lysine functional groups, wherein the lysine functional groups comprise a label. 5. The lectin of claim 4 , wherein said label is a fluorophore or biotin. 6. The lectin of claim 1 , wherein the peptide modules are derived from RSL ( Ralstonia solanacearum lectin), BambBL ( Burkholderia ambifaria lectin), BC2LL-nt ( Burkholderia cenocepacia lectin), HPA ( Helix pomatia lectin), discoidin ( Dictyostelium discoideum lectin), CTX-B (cholera toxin lectin) lectins, B5 type bacterial toxins, AAA ( Anguilla anguilla lectin), and adenovirus lectin. 7. A method for producing the monomeric, single polypeptide chain lectin of claim 1 , said method comprising: transforming a host cell with nucleic acid encoding the monomeric, single chain lectin, culturing said host cell in culture medium under conditions for the expression of the monomeric, single polypeptide chain lectin, isolating the monomeric, single polypeptide chain lectin from the host cells or the culture medium. 8. A method for identifying glycosylation epitopes on a cell surface in vitro, said method comprising: contacting cells with the lectin of claim 1 , wherein the glycosylation epitopes are identified when the lectin binds to the cell surface glycan.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10247734B2 cover?
Multimenic lectins having a β-propeller architecture, formed from monomer modules of approximately 30 to 60 amino acids, in which the binding sites to the glycans are situated on a given side of the proteins and the O-terminus and N-terminus ends of the peptide chains on the other side of the proteins, characterized in that they are formed from 4 to 7 monomer modules, a single, or a plurality o…
Who is the assignee on this patent?
Centre Nat Rech Scient, Univ Joseph Fourier
What technology area does this patent fall under?
Primary CPC classification G01N33/68. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).